Clinical Trial Update: Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065) [Phase 3]

View source ↗

Summary

Phase 3 trial of Grazoprevir and Elbasvir combination for chronic hepatitis C genotypes 1, 4, and 6 completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Elbasvir (elbasvir)
• Grazoprevir (grazoprevir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2017-01-19